Field Study (STRT-498-0) Field Studies include those opportunities outside of the regular curriculum in which a student is working with an outside company or non-profit organization to address a real-world business challenge for course credit under the oversight of a faculty member.
Healthcare Strategy (STRT-443-0) This course delves into the strategic issues faced by healthcare firms. We will use concepts from the core strategy course (STRT-431) as an organizing framework, and discuss where and why the healthcare sector deviates from the norm. For example, what is the role of competitive positioning when quality is so difficult to measure? How can you remain profitable if you compete against not-for-profits who don't face taxes?
Because a great deal of healthcare strategy relies on understanding the nitty-gritty of particular industries, we will spend time learning about several of these, including health insurance, hospitals, pharmaceuticals, and medical devices. Although our focus is on private firms in the U.S., we will (of necessity) be discussing the role of the government in regulating and providing healthcare, and (time permitting) discuss some international issues. This is a lecture and case-based discussion course with group projects and a final exam.
Business Strategy (STRT-431-0) Strategy is the set of objectives, policies and resource commitments that collectively determine how a business positions itself to create wealth for its owners. This course introduces students to principles and conceptual frameworks for evaluating and formulating business strategy. Topics include the boundaries of the firm, the analysis of industry economics, strategic positioning and competitive advantage, and the role of resources and capabilities in shaping and sustaining competitive advantages.
Create & Capture Value in the Chinese Healthcare Market (HCAK-973-5) Surpassing approximately ten trillion yuan ($1.4 trillion) in 2021, the Chinese Healthcare market ranks as the second largest in the world. The recent growth in this market is driven by a rapid expansion of the share of the public covered by basic medical insurance as well as an increase in the types of technologies that are covered.
Beyond simply an emerging as a dominant consumer of healthcare technology, China is rapidly becoming a source of innovation in biopharmaceuticals, medical devices, and digital health. What was once a market or either 'me-too' or at times 'me -worse' technology has evolved into a supplier of cutting-edge medical solutions. Some of these solutions are targeted at specific nuances of the Chinese market while others will generate value globally.
It is now clear that any healthcare decision maker over the next several decades will need to have an understanding of this market and its role in the global healthcare ecosystem. It is also clear that success in the Chinese market will not be achieved by simply applying modified versions of global strategies. The sheer scope of the market combined with the complexity of healthcare and an active government interested in domestic production requires careful consideration of the sources of value creation and capture in this market.
In addition, managers in domestic Chinese firms need to more broadly understand the needs of other global healthcare markets and how their technologies can be used to create and capture global value. Absent that understanding, domestic firms are unlikely to be able to optimally structure the investments and partnerships with global firms.
Kellogg's 'Deep Dive: Chinese Healthcare Market' combines in class case and lecture-based learning, leading practitioner guest lectures, a breadth of networking opportunities, and cultural immersion opportunities designed to prepare future business decisionmakers in healthcare to interact with the Chinese market.
Field Study (HCAK-498-5) Independent Study
